What are the treatment options for male low libido?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Male Low Libido

Testosterone replacement therapy (TRT) is the first-line treatment for male low libido when associated with hypogonadism, showing significant improvements in sexual desire and activity. 1

Diagnostic Approach

Before initiating treatment, determine if low libido is associated with:

  • Hypogonadism (testosterone <300 ng/dL)
  • Erectile dysfunction
  • Psychological factors
  • Medication side effects
  • Chronic illness

Treatment Algorithm

1. For Low Libido with Hypogonadism

First-line: Testosterone Replacement Therapy

  • Forms available:

    • Transdermal (gels): Most convenient, easy to use 2
    • Intramuscular injections: More cost-effective ($156.24 vs $2135.32 annually for transdermal) 2
    • Oral testosterone: Emerging option with comparable efficacy 3
    • Buccal and nasal formulations 4
  • Dosing:

    • Intramuscular: 100-200 mg every 2 weeks or 50 mg weekly 5
    • Target testosterone levels: 450-600 ng/dL (mid-normal range) 5
  • Monitoring:

    • Check testosterone levels 2-3 months after initiation
    • Monitor hemoglobin and hematocrit for polycythemia
    • Assess cardiovascular status regularly 5
  • Contraindications:

    • Desire for fertility (TRT suppresses spermatogenesis) 5
    • Prostate cancer, breast cancer
    • Severe sleep apnea
    • Uncontrolled heart failure
    • Recent cardiovascular events 5, 6

Alternative for Men Desiring Fertility

  • Human chorionic gonadotropin (hCG): 500-2500 IU, 2-3 times weekly 5

    • Stimulates endogenous testosterone without suppressing spermatogenesis
    • Consider adding FSH injections if needed after testosterone normalizes
  • Enclomiphene citrate:

    • Blocks estrogen receptors at hypothalamic level
    • Increases endogenous testosterone while preserving fertility 5
    • Not recommended for men with estrogen receptor-positive malignancies

2. For Low Libido with Normal Testosterone

Psychological Interventions

  • Sexual skills training
  • Cognitive behavioral therapy (individual or online) 2

Address Underlying Causes

  • Review and modify medications that may affect libido
  • Treat depression if present
  • Manage chronic conditions

3. For Low Libido with Erectile Dysfunction

  • PDE5 inhibitors: First-line for erectile dysfunction
  • Combination therapy: TRT plus PDE5 inhibitors for men with hypogonadism and erectile dysfunction 7
  • Other options for refractory cases:
    • Intracavernous injections 2
    • Vacuum erection devices (90% initial efficacy) 2
    • Low-intensity shock wave therapy (LI-SWT) for mild vasculogenic ED 2

Efficacy of TRT for Low Libido

Recent high-quality evidence from the TRAVERSE study (2024) showed that TRT in hypogonadal men with low libido:

  • Significantly improved sexual activity compared to placebo
  • Enhanced sexual desire
  • Improved hypogonadal symptoms
  • Effects were maintained for at least 24 months
  • Did not significantly improve erectile function 1

Potential Side Effects of TRT

  • Erythrocytosis (2.8-17.9%, dose-dependent)
  • Suppression of spermatogenesis
  • Peripheral edema
  • Emotional lability
  • Potential cardiovascular effects (long-term safety uncertain) 5, 6
  • Gynecomastia
  • Sleep apnea (especially in obese patients or those with lung disease)
  • Changes in lipid profile 6

Important Considerations

  • Discontinuation rates for TRT range from 30% to 62% 2
  • Lifestyle modifications (weight loss, physical activity) can improve testosterone levels in obese men 5
  • Regular monitoring is essential to assess efficacy and detect adverse effects
  • Evidence on long-term benefits or harms of testosterone treatment beyond 24 months is limited 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pharmacology of testosterone replacement therapy preparations.

Translational andrology and urology, 2016

Guideline

Treatment of Hypogonadotropic Hypogonadism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.